2015
Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis
Chindelevitch L, Menzies NA, Pretorius C, Stover J, Salomon JA, Cohen T. Evaluating the potential impact of enhancing HIV treatment and tuberculosis control programmes on the burden of tuberculosis. Journal Of The Royal Society Interface 2015, 12: 20150146. PMID: 25878131, PMCID: PMC4424692, DOI: 10.1098/rsif.2015.0146.Peer-Reviewed Original ResearchConceptsAntiretroviral therapyTB incidenceTB burdenBurden of tuberculosisTuberculosis Control ProgrammePotential epidemiological impactART eligibilityMortality benefitTB programsHIV treatmentTB prevalenceTuberculosis incidenceEpidemiological impactART useProgram improvementHIVTreatment effectivenessIncidenceMortalityGreater reductionBurdenTBSaharan AfricaControl programsEligibility
2014
The Impact of Antiretroviral Therapy on Mortality in HIV Positive People during Tuberculosis Treatment: A Systematic Review and Meta-Analysis
Odone A, Amadasi S, White RG, Cohen T, Grant AD, Houben RM. The Impact of Antiretroviral Therapy on Mortality in HIV Positive People during Tuberculosis Treatment: A Systematic Review and Meta-Analysis. PLOS ONE 2014, 9: e112017. PMID: 25391135, PMCID: PMC4229142, DOI: 10.1371/journal.pone.0112017.Peer-Reviewed Original ResearchConceptsHIV-positive peopleAntiretroviral therapyTB treatmentTuberculosis treatmentSystematic reviewHIV-positive TB casesCoverage of ARTRisk of deathMain outcome measuresOutcomes of interestTB casesDual epidemicsTB therapyRelative riskOutcome measuresPooled estimatesStudy populationProportion of individualsFatality ratioPositive peopleMeta-AnalysisART statusClinical settingManual searchMortality
2011
Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994–2009
Jenkins HE, Zignol M, Cohen T. Quantifying the Burden and Trends of Isoniazid Resistant Tuberculosis, 1994–2009. PLOS ONE 2011, 6: e22927. PMID: 21829557, PMCID: PMC3146514, DOI: 10.1371/journal.pone.0022927.Peer-Reviewed Original ResearchConceptsIsoniazid preventive therapyIncident TB casesTB casesHIV prevalence countriesHigh HIV prevalence countriesPrevalence countriesHigh HIV prevalence areasRetreatment TB casesHIV prevalence areasIsoniazid-resistant tuberculosisControl of tuberculosisEffect of INHObserved time trendsWorld Health OrganizationPreventive therapyResistant tuberculosisIncident casesTreatment successPrevalence areasIsoniazid resistanceMultidrug resistanceHealth OrganizationTuberculosisINHNational data
2008
Challenges in Estimating the Total Burden of Drug-resistant Tuberculosis
Cohen T, Colijn C, Wright A, Zignol M, Pym A, Murray M. Challenges in Estimating the Total Burden of Drug-resistant Tuberculosis. American Journal Of Respiratory And Critical Care Medicine 2008, 177: 1302-1306. PMID: 18369201, PMCID: PMC2720088, DOI: 10.1164/rccm.200801-175pp.Peer-Reviewed Original ResearchConceptsDrug-resistant tuberculosisDrug resistance surveillanceHIV/TB coinfectionAnti-Tuberculosis Drug Resistance SurveillanceResistance surveillanceSentinel site surveillanceBurden of tuberculosisMultidrug-resistant diseaseMultidrug-resistant tuberculosisTB control programsTB coinfectionTB casesHigh burdenMethodologic obstaclesSurveillance studyNew casesTotal burdenTuberculosisLaboratory capacityBurdenSurveillanceControl programsDiagnostic technologiesRecent recognitionTrue extent
2006
Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV–tuberculosis coinfected populations
Cohen T, Lipsitch M, Walensky RP, Murray M. Beneficial and perverse effects of isoniazid preventive therapy for latent tuberculosis infection in HIV–tuberculosis coinfected populations. Proceedings Of The National Academy Of Sciences Of The United States Of America 2006, 103: 7042-7047. PMID: 16632605, PMCID: PMC1459015, DOI: 10.1073/pnas.0600349103.Peer-Reviewed Original ResearchConceptsIsoniazid preventive therapyDrug-resistant TBCommunity-wide isoniazid preventive therapyPreventive therapyTuberculosis infectionTB controlLatent Mycobacterium tuberculosis infectionLatent tuberculosis infectionProportion of patientsMycobacterium tuberculosis infectionIncidence of TBTuberculosis case notificationCommunity-wide implementationEmergence of HIVCommunity-wide strategiesHIV-tuberculosisTB-HIVCoinfected individualsTB epidemicCase notificationTreatment policyHIVTherapyInfectionTB